Showing results (521-530 of 1,018) with videos related to

Sort By:
Pageof 102
The EPMA Journal|March 9, 2021
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicineLenka Koklesova, Marek Samec, Alena Liskova, et al.
Infection|October 17, 2012
Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control studyG B Orsi, A Bencardino, A Vena, et al.
Journal of Occupational and Environmental Medicine|July 31, 2020
A Time-Series Analysis of the Association Between Occupational Health Policies and Opioid Prescription Patterns in United States Active Duty Military Service Members From 2006 to 2018Kalyn C Jannace, Nicholas A Giordano, Rosenie Thelus, et al.
Medical Care Research and Review : MCRR|July 7, 2025
Hospital Patient Experience Worsened With the COVID-19 Pandemic, Especially for Older Adults, and Remains Worse than BeforeMegan K Beckett, Christopher W Cohea, Debra Saliba, et al.
Frontiers in Public Health|April 10, 2024
Opioid utilization after orthopaedic trauma hospitalization among Medicaid-insured adultsNicholas A Giordano, Guantao Zhao, Manvitha Kalicheti, et al.
Vascular Surgery|October 5, 2001
Correlation of Tc-99m-red blood cell phleboscintigraphy with clinical severity of chronic venous diseaseA Giordano, M L Calcagni, F Rulli, et al.
La Chirurgia Degli Organi Di Movimento|September 24, 2004
Manipulative therapy in the treatment of benign cervicobrachialgia of mechanical originB Moretti, A Vetro, R Garofalo, et al.
Human Molecular Genetics|December 23, 1999
Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesisG Guanti, N Resta, C Simone, et al.
Cellular and Molecular Neurobiology|June 18, 2002
Coupling of dopamine receptors to G proteins: studies with chimeric D2/D3 dopamine receptorsTal Ilani, C Simone Fishburn, Berta Levavi-Sivan, et al.
Pharmacoeconomics|October 18, 2021
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United KingdomSiu Hing Lo, Ksenija Gorni, C Simone Sutherland, et al.
Pageof 102